Compare Rex Fang & Innovation Equity Premium Income ETF (FEPI) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rex Fang & Innovation Equity Premium Income ETF vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.81 (market cap $753.07M), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 9.4× Rex Fang & Innovation Equity Premium Income ETF's market cap, and Rex Fang & Innovation Equity Premium Income ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rex Fang & Innovation Equity Premium Income ETF for 57 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| FEPI | IONS | |
|---|---|---|
Market Cap | $753.07M | $7.10B |
Volume | 329,956 | 2,027,457 |
Sector | Income / Options Overlay | Health |
52-Week High | $49.54 | $86.50 |
52-Week Low | $37.98 | $42.38 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | — | $6.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.28, showing minimal daily movement with a 0.14% gain. The ETF employs a covered call strategy on AI and mega-cap tech stocks, generating substantial weekly dividends averaging $0.20-0.21 per share. Technical indicators show a bullish trend with strong moving average support, while oscillators remain neutral. Recent news highlights FEPI's 25% yield but notes underperformance compared to peers in total returns.
FEPI offers high income potential through its covered call strategy but faces capped upside and concentrated tech exposure risks. The ETF's performance depends heavily on AI sector volatility and options pricing efficiency. While attractive for income-focused investors, total return potential may lag broader market indices during strong bull markets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
